Skip to main content
    L

    Lantheus Holdings Inc (LNTH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $101.72
    +0.13 (+0.13%)

    Market Cap: $6.64B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Lantheus Holdings Inc (LNTH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Lantheus Holdings (LNTH) trades at 17.9x trailing earnings and 4.5x sales. Its P/E of 17.9x is above its 5-year median of 15.2x. Its forward P/E is 14.5x. The median P/E across 10 similar companies is 21.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 23.4% higher over the next year. Its free cash flow yield is 5.6%.

    MultipleValue
    P/E (trailing)17.9x
    Forward P/E14.5x
    Price to sales4.5x
    Price to book5.1x
    EV/EBITDA15.1x
    Price to FCF17.7x
    EV/FCF17.4x
    PEG0.6
    FCF yield5.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 4.7% above 17.1x, its P/S is 36.4% above 3.3x and its P/B is 16.4% below 6.1x.

    MultipleCurrent5-year median10-year median
    P/E17.9x15.2x17.1x
    P/S4.5x4.3x3.3x
    P/B5.1x5.9x6.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 107 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 10.0x in 2023 to 59.0x in 2021.

    Year endPriceP/EP/SP/B
    2025$66.5511.4x3.0x4.0x
    2024$89.4613.2x4.1x5.7x
    2023$62.0010.0x3.3x5.3x
    2022$50.9612.1x3.8x7.8x
    2021$28.8959.0x4.6x4.2x
    2020$13.4923.7x2.1x1.8x
    2019$20.5117.5x2.4x7.2x
    2018$15.6516.3x1.8x8.7x
    2017$20.4519.3x2.4x34.5x
    2016$8.6011.9x0.9xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LNTH

    What is LNTH's forward P/E ratio?

    Lantheus Holdings has a forward P/E ratio of 14.5x.

    Is LNTH stock overvalued?

    GNG's valuation label for LNTH is Fairly valued. Its P/E of 17.9x compares with a median of 21.8x across 10 similar companies.

    What is LNTH's price to sales ratio?

    Lantheus Holdings has a price to sales ratio of 4.5x.

    What is Lantheus Holdings's average P/E ratio over 5 years?

    Lantheus Holdings's median P/E over the last 5 years is 15.2x, from 60 month-end values through Oct 2026.

    What is LNTH's PEG ratio?

    Lantheus Holdings has a PEG ratio of 0.6.